R&D Archives -

Ipsen adds Blueprint’s FOP rare disease drug to pipeline for $535m

https://pharmaphorum.com/news/ipsen-adds-blueprints-fop-rare-disease-drug-to-pipeline-for-535m/

Sanofi opens digital biologics manufacturing site

https://pharmaphorum.com/news/sanofi-opens-digital-biologics-manufacturing-site/

BioNTech and Vir prepare mega-IPOs after flurry of launches

https://pharmaphorum.com/news/biontech-and-vir-prepare-mega-ipos-after-flurry-of-launches/

After Alzheimer’s trial woes, Biogen’s R&D chief quits to head up biotech VC

https://pharmaphorum.com/news/after-alzheimers-trial-woes-biogens-rd-chief-quits-to-head-up-biotech-vc/

Rare disease patients unconvinced by health secretary’s post-Brexit research plans

https://pharmaphorum.com/news/rare-disease-patients-unconvinced-by-health-secretarys-post-brexit-rd-plans/

Novartis announces positive results from asthma combinations

https://pharmaphorum.com/news/novartis-announces-positive-results-from-asthma-combination-therapies/

CNS Summit 2019 | Oct 31 – Nov 3, Boca Raton, FL

https://pharmaphorum.com/events/cns-summit-2019/

Immunicum continues cell therapy trials after positive kidney cancer readout

https://pharmaphorum.com/news/immunicum-to-push-on-with-immunotherapy/

Evotec announces potential $850m R&D partnership with Takeda

https://pharmaphorum.com/news/evotec-announces-potential-850m-rd-partnership-with-takeda/

Search